Ho Young Huh

Former Interim Executive Chairman at Geron Corp.

Ho Young Huh

Ho Young Huh

Former Interim Executive Chairman at Geron Corp.

Overview
Career Highlights

Nektar Therapeutics
Geron Corp.
Quintessa Investment Co. Ltd.

RelSci Relationships

3200

Number of Boards

26

Birthday

1970

Age

49

Relationships
RelSci Relationships are individuals Ho Young Huh likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Rezolute, Inc.

Relationship likelihood: Strong

Chairman of the Board, President & Chief Executive Officer at Geron Corp.

Relationship likelihood: Strong

Founder, President & Chief Executive Officer at Calithera Biosciences, Inc.

Relationship likelihood: Strong

Former Chief Operating Officer, Trustee & Executive Vice President at Sanford Burnham Prebys Medical Discovery Institute

Relationship likelihood: Strong

Chairman, President & Chief Executive Officer at CytomX Therapeutics, Inc.

Relationship likelihood: Strong

Former Chief Medical Officer at Genentech, Inc.

Relationship likelihood: Strong

Founder at SciDose LLC

Relationship likelihood: Strong

Co-Founder at Lunglife AI, Inc.

Relationship likelihood: Strong

Chief Operating Officer & Chief Financial Officer at Nektar Therapeutics

Relationship likelihood: Strong

Partner at Third Rock Ventures LLC

Relationship likelihood: Strong

Paths to Ho Young Huh
Potential Connections via
Relationship Science
You
Ho Young Huh
Former Interim Executive Chairman at Geron Corp.
Education
BS Biochemistry

Founded in 1769, Dartmouth is a member of the Ivy League and consistently ranks among the world's greatest academic institutions. Dartmouth has forged a singular identity for combining its deep commitment to outstanding undergraduate liberal arts and graduate education with distinguished research and scholarship in the Arts & Sciences and its three leading professional schools—the Geisel School of Medicine, Thayer School of Engineering, and the Tuck School of Business.

MD

Founded in 1898, and affiliated with what is now NewYork-Presbyterian Hospital since 1927, Weill Cornell Medical College is among the top-ranked clinical and medical research centers in the country. In addition to offering degrees in medicine, Weill Cornell also has PhD programs in biomedical research and education at the Weill Cornell Graduate School of Medical Sciences, and with neighboring Sloan-Kettering Institute and The Rockefeller University, has established a joint MD-PhD program for students to intensify their pursuit of Weill Cornell's triple mission of education, research, and patient care. Weill Cornell Medical College is divided into 24 basic science and patient care departments that focus on the sciences underlying clinical medicine and/or encompass the study, treatment, and prevention of human diseases. In addition to its affiliation with NewYork-Presbyterian Hospital, Weill Cornell Medical College and the Weill Cornell Graduate School of Medical Sciences maintain major affiliations with Memorial Sloan-Kettering Cancer Center, The Rockefeller University, the Hospital for Special Surgery, as well as with the metropolitan-area institutions that constitute NewYork-Presbyterian Healthcare Network. Weill Cornell Medical College and the Weill Cornell Graduate School of Medical Sciences are accredited by the Liaison Committee for Medical Education of the American Medical Association and the Association of American Medical Colleges.

Cornell is a privately endowed research university and a partner of the State University of New York. As the federal land-grant institution in New York State, they have a responsibility—unique within the Ivy League—to make contributions in all fields of knowledge in a manner that prioritizes public engagement to help improve the quality of life in our state, the nation, the world.

Ph.D. in Genetics & Cell Biology
Career History
Interim Executive Chairman
Current

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.

Chairman & Chief Executive Officer
2015 - Current

pH Pharma Co. Ltd. develops diagnostic substances and healthcare products. It offers php-303, php-201, ab-101, tria, nuvesse, alpine and torpedo products. The company was founded by Hoyoung Huh on September 28, 2015 and is headquartered in Seoul, South Korea.

Chief Operating Officer & Senior Vice President of Business Development & Marketing
Prior

Nektar Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms, which are designed to improve the benefits of drugs for patients. Its product pipeline consists of drug candidates across a number of therapeutic areas, including oncology, pain, anti-infectives, anti-viral and immunology. Nektar's research and development activities involve small molecule drugs, peptides and other potential biologic drug candidates. Its drug candidates are designed to improve the pharmacokinetics, pharmacodynamics, half-life, bioavailability, metabolism or distribution of drugs and improve the overall benefits and use of a drug for the patient.

Boards & Committees
Director
Prior - 2015

Bionik Laboratories Corp. engages in the provision of rehabilitation and mobility solutions to individuals with neurological disorders. Its products include InMotion ARM, InMotion HAND, and InMotion WRIST. The company was founded by Michal Prywata and Thiago Caires on January 8, 2010 and is headquartered in Toronto, Canada.

Independent Director
Prior - 2013

EOS SpA manufactures biopharmaceutical products. The firm develops novel medicines for the treatment of cancer. Its products include E/CEP-18770, an orally active and reversible P2 threonine boronic acid inhibitor; and E-3810, a novel small molecule, which is a potent and selective inhibitor of vascular endothelial growth factor and fibroblast growth factor receptors. The company was founded in June 2006 by Silvano Spinelli, Gabriella Camboni, Ennio Cavalletti and Jacques Theurillat and is headquartered in Milan, Italy.

Member, Compensation Committee
2011 - 2014

Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.

Director
Prior

BayBio brings together the collective strength and experience of the world’s most innovative and productive life science cluster, helping companies grow, connect and advocate to solve some of humanity’s most pressing challenges. BayBio provides comprehensive support and solutions tailored to the unique needs of nearly 1000 Bay Area life science companies and institutions, delivering tangible value through group purchasing savings, capital access, government affairs & advocacy, networking and best-practice sharing. BayBio also supports the future of bioscience innovation through the BayBio Institute’s work in science education, career development and entrepreneurship.

Transactions
Details Hidden

Rezolute, Inc. raised money in a private placement transaction

Details Hidden

Rezolute, Inc. raised money in a private placement transaction

Details Hidden

Rezolute, Inc. raised money in a private placement transaction

Investments
Details Hidden

StemPar Sciences, Inc. develops cancer drugs treatments. It provides cancer drugs that attack solid tumors by simultaneously disrupting their source of energy and their ability to repair chemotherapy/radiation induced DNA damage. The company was founded by Hoyoung Huh and Mircea Florin Mihaescu in 2012 and is headquartered in Mill Valley, CA.

Details Hidden

Konus Advisory Group, Inc. operated as a boutique advisory firm. It served the healthcare industries in markets including Asia, Latin America, and the Middle East. The firm provided targeted consulting to select clients as they navigate new geographies, advising both the United States and European organizations. The company was founded by Michael Masterson, Nevan Charles Elam and Hoyoung Huh in 2012 and was headquartered in Menlo Park, CA.

Public Holdings
Restricted data only for RelSci Professional users.
Events
Speaker
3rd Annual Partnering For Cures

Partnering for Cures is FasterCures' annual meeting that brings together diverse participants to discuss and solve the crucial issues facing the medical research world today. Partnering for Cures is structured with thought-provoking panels that host well-known speakers from the different sectors of the medical world; presenters from organizations that are boasting innovative approaches to the issues facing health; pro-bono, personalized advice from experts across medical research fields; and a unique partnering systems that allows conference participants to schedule meetings throughout the weekend to collaborate and create new approaches to save and improve lives.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Ho Young Huh. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Ho Young Huh's profile does not indicate a business or promotional relationship of any kind between RelSci and Ho Young Huh.